2BB score and signals
Kyverna Therapeutics, Inc.’s current 2BB score is 39 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 52 | Moderate |
| Momentum | 43 | Stable |
| Financial strength | 10 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 40 | Moderate |
Company facts
| Headquarters | Emeryville, California, United States |
| Founded | 2018 |
| Employees | 129 |
| 52-week range | $2.96 – $13.67 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.7018 | — | $0.00 |
| 2026-08-18 | — | -0.6919 | — | $0.00 |
| 2026-05-12 | -0.66 | -0.7667 | $0.00 | $0.00 |
| 2026-03-26 | -0.8 | -0.8755 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish